| Methods | n = 9, 1 centre Allocation concealment: local independent randomization Baseline similarity: age (D) Blinding: caregivers Cointerventions: not described Withdrawals: none Losses to follow‐up: none |
|
| Participants | Inclusions: Risk factor: sepsis or surgery; mechanical ventilation; CXR infiltrates, PaO2 < 55 mmHg on room air or P/F ratio < 250 mmHg, no evidence of volume overload | |
| Interventions | Continuous IV PGE1, dose titrated to 30 ng/kg/minute (43.2 mcg/kg/day) for 48‐72 hours, or placebo | |
| Outcomes | Mortality: RR 0.80 (95% CI 0.52 to 1.24) | |
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Allocation concealment (selection bias) | Low risk | A ‐ Adequate |